main-logo

ICD-10 Code C16.3 | Malignant neoplasm of pyloric antrum Symptoms, Diagnosis, Billing

Malignant neoplasm of the pyloric antrum is a type of gastric cancer that arises in the lower part of the stomach, specifically the pyloric region. This condition is clinically significant due to its potential for metastasis and associated complications. Accurate coding with ICD-10 Code C16.3 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.

What is ICD-10 Code C16.3 for Malignant neoplasm of pyloric antrum?

ICD-10 Code C16.3 specifically denotes a malignant neoplasm located in the pyloric antrum of the stomach. This code is utilized when documenting cases of gastric cancer that originate in this region, which may lead to complications such as obstruction or bleeding. It is crucial for accurate clinical documentation and billing to ensure appropriate treatment and resource allocation.

ICD-10 Code C16.3 – Clinical Definition and Explanation of Malignant neoplasm of pyloric antrum

Malignant neoplasm of the pyloric antrum is primarily caused by genetic mutations and environmental factors, including diet and Helicobacter pylori infection. The condition can progress rapidly, leading to significant morbidity and necessitating prompt medical intervention.

Key Clinical Features:

  • Common symptoms include abdominal pain, nausea, vomiting, and weight loss.
  • Patients may present with signs of gastric obstruction or bleeding.
  • Epidemiologically, it is more prevalent in older adults and those with a history of gastric disorders.
  • Diagnosis typically involves endoscopy and biopsy for histological confirmation.

ICD-10 Code C16.3 for Malignant neoplasm of pyloric antrum – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C16.3 is used to document the diagnosis of malignant neoplasm of the pyloric antrum, facilitating a structured approach to patient care. It aids in capturing symptoms, assessments, and treatment plans in both acute and chronic care settings.

What Does ICD-10 Code C16.3 for Malignant neoplasm of pyloric antrum Mean in SOAP Notes?

ICD-10 Code C16.3 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of malignant neoplasm of the pyloric antrum. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C16.3 – Malignant neoplasm of pyloric antrum

The management of malignant neoplasm of the pyloric antrum often requires hospitalization for comprehensive treatment. Surgical intervention, chemotherapy, and supportive care are critical components of the treatment plan.

Antibiotic Therapy:

  • Not applicable as this is not an infectious condition.

Supportive Care:

  • Nutritional support to manage weight loss.
  • Pain management strategies.
  • Hydration and electrolyte balance.

Infection Control:

  • Standard precautions to prevent hospital-acquired infections.

How to Document Symptoms of Malignant neoplasm of pyloric antrum (ICD-10 C16.3) in SOAP Notes

Subjective:

  • Patient reports persistent abdominal pain and discomfort.
  • Complaints of nausea and occasional vomiting.
  • Notable weight loss over the past month.
  • History of early satiety and changes in appetite.

Objective:

  • Abdominal examination reveals tenderness in the epigastric region.
  • Vital signs: BP 110/70 mmHg, HR 85 bpm, Temp 98.6°F.
  • Endoscopy findings show a mass in the pyloric antrum.
  • Biopsy results confirm malignant cells.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Malignant neoplasm of pyloric antrum (ICD-10 Code C16.3)

Assessment:

  • Diagnosis: Malignant neoplasm of pyloric antrum, stage II.
  • ICD-10 Code: C16.3.
  • Contributing factors include age and possible H. pylori infection.
  • Patient exhibits significant weight loss and nutritional deficiencies.

Plan:

  • Refer for surgical evaluation and potential resection.
  • Initiate chemotherapy regimen as per oncology guidelines.
  • Provide dietary consultation for nutritional support.
  • Schedule follow-up in one month to assess treatment response.

Treatment & Plan Section for ICD-10 Code C16.3 – Malignant neoplasm of pyloric antrum

  • First-line treatment includes surgical resection of the tumor.
  • Chemotherapy may be indicated based on staging and histology.
  • Nutritional support and counseling are essential for recovery.
  • Regular monitoring through imaging and endoscopy for recurrence.

Using ICD-10 Code C16.3 for Malignant neoplasm of pyloric antrum in Billing & SOAP Note Compliance

  • Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
  • Use C16.3 in conjunction with relevant CPT codes for surgical and chemotherapy services.
  • Maintain compliance with coding guidelines to support reimbursement.
  • Document any complications or additional procedures performed.

ICD-10 Code C16.3 in Medical Billing and Insurance for Malignant neoplasm of pyloric antrum

ICD-10 Code C16.3 is critical for billing purposes in hospital, ER, or oncology settings, ensuring accurate reimbursement for services rendered.

Billing Notes:

  • Document all relevant clinical findings and treatment plans to support the claim.
  • Use C16.3 in conjunction with appropriate CPT codes for surgical and medical interventions.
  • Ensure that all documentation aligns with coding guidelines to avoid denials.
  • Include any complications or additional diagnoses that may affect treatment.

Common CPT Pairings:

CPT CodeDescription
43191Esophagogastroduodenoscopy (EGD) with biopsy.
43620Laparoscopic gastric resection.
96413Chemotherapy administration, intravenous.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C16.3 for Malignant neoplasm of pyloric antrum

What are the common symptoms of malignant neoplasm of pyloric antrum?

Common symptoms include abdominal pain, nausea, vomiting, weight loss, and early satiety. Patients may also experience gastrointestinal bleeding, which can be a critical sign requiring immediate medical attention.

How is malignant neoplasm of pyloric antrum diagnosed?

Diagnosis typically involves endoscopic examination and biopsy to confirm the presence of malignant cells. Imaging studies such as CT scans may also be utilized to assess the extent of disease.

What treatment options are available for this condition?

Treatment often includes surgical resection of the tumor, chemotherapy, and supportive care to manage symptoms and nutritional needs. The specific approach depends on the stage of cancer and overall patient health.

Is there a risk of recurrence after treatment?

Yes, there is a risk of recurrence after treatment for malignant neoplasm of the pyloric antrum. Regular follow-up and monitoring through imaging and endoscopy are essential to detect any signs of recurrence early.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved